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Abstract
We used for the first time a right ventricular exclusion procedure for the treatment of hepatocellular carcinoma
metastatic to the right ventricle. Our case report shows that this surgical option can be effective as rescue therapy
for right ventricular outflow tract obstruction secondary to myocardial metastasis in critically ill patients. Most nota-
bly, this technique can prevent inadvertent dislodgement of tumor cells.
Background
Right ventricular outflow tract obstruction secondary to
myocardial metastasis from hepatocellular carcinoma
(HCC) represents a rare event and portends a poor
prognosis [1-4]. The clinical picture is chiefly dominated
by severe cardiorespiratory compromise that may lead
to cardiac arrest. Surgical resection with therapeutic
intent is not an option for the majority of patients with
metastatic involvement of the heart. However, symptom
relief after palliative surgery can improve quality of life.
We hereby present a clinical case of intraventricular car-
diac metastasis from HCC leading to right ventricular
outflow tract obstruction. We used for the first time a
right ventricular exclusion procedure as rescue therapy
to relieve mechanical obstruction to blood flow and
avoid life-threatening hemodynamic instability. In addi-
tion, this procedure can prevent inadvertent dislodge-
ment of tumor cells.
Case Presentation
A 46-year-old female patient complained of general
weakness and increasing dyspnea for 1 month. She had
been diagnosed 14 months earlier with a hepatocellular
carcinoma for which she underwent extended right
hepatectomy. After surgery, the patient was treated
twice with transarterial chemoembolization for small
recurrent HCC lesions. At the time of the second che-
moembolization, computed tomography (CT) and mag-
netic resonance imaging (MRI) revealed a right
ventricular mass resulting in right ventricular outflow
tract obstruction. The patient was offered surgery but,
being otherwise asymptomatic, she refused treatment at
that time.
Two months after hospital discharge, she developed
marked exercise intolerance, dyspnea, and orthopnea.
The patient was admitted for further investigation. Her
pulse rate was 120 beats per minute, blood pressure 90/
45 mmHg, and respiratory rate was 35 breaths per min-
ute. A CT scan (Figure 1) and echocardiography (Figure
2) revealed a large tumor mass in the right ventricle
extending to the right ventricular outflow tract and the
proximal main pulmonary artery. The mass occasionally
caused obstruction of the flow of blood through the tri-
cuspid valve into the right ventricle. CT scan of abdo-
men showed no local recurrence of the liver tumor. The
patient was operated upon urgently; a standard proce-
dure was performed with moderate hypothermia, cardio-
pulmonary bypass, and bicaval cannulation. The heart
was arrested with a cold blood cardioplegic solution
administered intermittently. At surgery, a right ventricu-
lotomy revealed a large cauliflower-like soft tissue mass
of gray-yellow color invading right ventricular myocar-
dium, the interventricular septum and septal papillary
muscles. The right and left pulmonary arteries were
temporarily occluded to prevent dislodging of tumor
cells. Debulking of the mass was performed to relieve
mechanical obstruction to blood flow, but the extensive
infiltrating nature of the tumor prohibited complete
removal. Owing to the incomplete resection, and
because of the fragility of tumor surface after debulking,
we reasoned that a right ventricular exclusion with total
cavopulmonary connection (TCPC) could offer a viable
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preventing dislodging. Therefore, the pulmonary and tri-
cuspid valves were closed using a continuous suture,
and the right ventriculotomy was closed with a patch.
The superior vena cava was then transected and anasto-
mosed to the upper aspect of the right pulmonary artery
(RPA). An intracardiac conduit was constructed by
using a GoreTex patch to direct inferior vena cava flow
into the lower part of the RPA. A 6 mm fenestration
was created to decompress the right side circulation.
Cardiopulmonary bypass was weaned off smoothly and
the immediate postoperative course was uneventful. The
patient was extubated on the postoperative day 2, and
she was transferred to ward on the postoperative day 6.
Shortness of breath and tachypnea improved signifi-
cantly after surgery. At oxygen flow rates of 3.0 L￿min
-1,
a stable oxygen saturation ≥ 85% was reached. Patholo-
gical examination confirmed the diagnosis of metastatic
HCC. The patient was subsequently placed on oral thali-
domide maintenance therapy.
The patient experienced attacks of exertional dyspnea,
and we performed transcatheter closure of the fenestra-
tion one month after TCPC. Arterial saturation
improved significantly to 94% after fenestration closure,
and exercise intolerance disappeared. Catheterization
revealed a patent TCPC conduit. The patients refused to
undergo the planned chemotherapy and radiotherapy
for residual tumor in the right ventricle. She passed
away four months after the surgery due to recurrence of
HCC in liver.
Discussion
Cases of HCC metastatic to the right ventricle are
exceedingly rare and generally have a dismal prognosis
[1-4]. There is only one report in the literature describ-
ing the use of cardiac surgery to remove a hepatocellular
carcinoma that had metastasized to the right ventricle
[4]. Management of metastasis to the heart is palliative
surgical excision and this was followed in our patient by
debulking of the mass to relieve mechanical obstruction
to blood flow and avoid life-threatening hemodynamic
instability. Most notably, the total right ventricular
exclusion procedure used in our patient provides a
means for avoiding tumor fragmentation, dislodgement,
or embolization.
To improve a poor prognosis of metastatic HCC, mul-
timodal approaches combining chemotherapy, radiother-
apy, and surgery may be useful. Interestingly, it has been
recently suggested that the oral multikinase inhibitor,
sorafenib, may produce a survival advantage in patients
with advanced HCC [5]. In conclusion, we used for the
first time a right ventricular exclusion procedure for the
treatment of HCC metastatic to the right ventricle. We
believe that this surgical option can be effective as res-
cue therapy for right ventricular outflow tract obstruc-
tion secondary to myocardial metastasis in critically ill
patients. Most notably, it can prevent inadvertent dislod-
gement of tumor cells.
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Figure 1 Computed tomography showing a mildly enhancing
mass (arrowhead) surrounded by contrast medium. The mass
was attached to the right ventricular wall, extending to the main
pulmonary artery.
Figure 2 Echocardiography showing a mass occupying most of
the right ventricle.
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